Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

30 Nov 2023 Evaluate

Aurobindo Pharma has informed that it enclosed the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..